openPR Logo
Press release

Gastric Antisecretory Drug Market Size Forecasted To Achieve 19.97 Billion By 2029 With Steady Growth

06-11-2025 06:56 AM CET | Health & Medicine

Press release from: The Business Research Company

Gastric Antisecretory Drug

Gastric Antisecretory Drug

Our market reports now include the latest updates on global tariffs, trade impacts, and evolving supply chain dynamics.

What Is the Gastric Antisecretory Drug Market Size and Projected Growth Rate?
The market for gastric antisecretory medicines has seen significant expansion in previous years. This market is set to increase from $14.87 billion in 2024 to $15.78 billion in 2025, with a compound annual growth rate of 6.2%. Factors that contributed to this growth in the past include higher levels of stress and inactive lifestyles, increasing incidences of helicobacter pylori infections, favorable government health initiatives, burgeoning medical tourism, and the rise in e-commerce and online pharmacy platforms.

The market for gastric antisecretory drugs is anticipated to experience robust growth in the upcoming years, reaching a size of $19.97 billion by 2029, with a CAGR at 6.1%. This expansion during the projection period is linked to the increasing occurrence of gastrointestinal disorders, the surge in the elderly population, enhanced cognizance regarding digestive health, development of the healthcare infrastructure, and a rise in the intake of fast and processed food. Key trends during the projection period encompass the broad use of NSAIDs, accessibility of antisecretory medications over the counter, advancements in drug delivery technologies, presence of generic medicines, and progress in combination therapies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/customise?id=24222&type=smp

What Are the Major Segments in the Gastric Antisecretory Drug Market?
The gastric antisecretory drug market covered in this report is segmented -

1) By Drug Class: Proton Pump Inhibitors (PPIs), H2 Receptor Antagonists, Antacids, Prostaglandin Analogs
2) By Route Of Administration: Oral, Intravenous, Topical
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
4) By Application: Gastroesophageal Reflux Disease, Peptic Ulcer Disease, Zollinger-Ellison Syndrome, Other Applications

Subsegments:
1) By Proton Pump Inhibitors (PPIs): Omeprazole, Esomeprazole, Lansoprazole, Pantoprazole, Rabeprazole, Dexlansoprazole
2)By H2 Receptor Antagonists: Ranitidine, Famotidine, Cimetidine, Nizatidine
3) By Antacids: Magnesium Hydroxide, Calcium Carbonate, Aluminum Hydroxide, Sodium Bicarbonate, Combination Antacids
4) By Prostaglandin Analogs: Misoprostol, Enprostil

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24222&type=smp

What Are The Driving Gastric Antisecretory Drug Market Evolution?
The surge in gastrointestinal disorders is expected to fuel the expansion of the gastric antisecretory drug market in the forthcoming years. These disorders impact the digestive system, including the stomach, intestines, and connected organs, resulting in symptoms such as discomfort, bloating, and disrupted bowel habits. The escalation in these disorders can mainly be attributed to unhealthy eating behaviors, where an excessive consumption of processed foods and insufficient fiber causes an imbalance in gut bacteria and hampers digestion. Gastric antisecretory drugs become an imperative need in such scenarios, as excess gastric acid can degrade the defensive lining of the digestive tract, leading to irritation or hurt that these drugs guard against by minimizing acid generation. For example, according to a ScienceDirect report in May 2025, a bibliographic database based in the US drew attention to approximately 23.5 million gastrointestinal endoscopies conducted in 2022. As a result, the escalating prevalence of gastrointestinal disorders is likely to stimulate the growth of the gastric antisecretory drug market.

Which Firms Dominate The Gastric Antisecretory Drug Market Segments?
Major companies operating in the gastric antisecretory drug market are Pfizer Inc., Bayer AG, AstraZeneca plc, Takeda Pharmaceutical Company Ltd., Sun Pharmaceutical Industries, Dr. Reddy's Laboratories, Chemo Biological, Spansules Pharmatech Pvt. Ltd., Phoenix Biologicals Pvt. Ltd., Centurion Remedies Private Limited, Solitaire Pharmacia Pvt. Ltd., Shreeji Pharma International, Estrellas Life Sciences Private Limited, 3s Corporation, Actiza Pharmaceutical Private Limited, Lark Laboratories, Cytonova Labs International Private Limited, Luckys Pharma Lab Pvt. Ltd., Lexicare Pharma Pvt. Ltd., Mustcure Healthcare LLP

What Are the Major Trends Shaping the Gastric Antisecretory Drug Market?
Key players in the gastric antisecretory drug market are honing their focus on the creation of superior products such as antisecretory compounds for extended relief. These compounds are agents that hinder or lessen the secretion of body fluids, especially gastric acid, by interacting with distinct cellular pathways or receptors. For instance, Akums Drugs and Pharmaceuticals, a pharmaceutical firm based in India, introduced Rabeprazole + Levosulpiride SR Capsules, a novel formulation for Gastrointestinal patients, in June 2024. This unique formula merges rabeprazole sodium, a powerful antisecretory compound which selectively blocks the H+/K+ ATPase in gastric parietal cells, and levosulpiride, known for its central antiemetic and antidopaminergic abilities. This capsule provides 40 mg of enteric-coated rabeprazole and 75 mg of sustained-release levosulpiride, promising targeted and enduring therapeutic effect. Its dual-action approach addresses both acid suppression and regulation of gastrointestinal motility.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/gastric-antisecretory-drug-global-market-report

Which Is The Largest Region In The Gastric Antisecretory Drug Market?
North America was the largest region in the gastric antisecretory drug market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric antisecretory drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Gastric Antisecretory Drug Market?
2. What is the CAGR expected in the Gastric Antisecretory Drug Market?
3. What Are the Key Innovations Transforming the Gastric Antisecretory Drug Industry?
4. Which Region Is Leading the Gastric Antisecretory Drug Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastric Antisecretory Drug Market Size Forecasted To Achieve 19.97 Billion By 2029 With Steady Growth here

News-ID: 4060590 • Views:

More Releases from The Business Research Company

Heating, Ventilation, And Air Conditioning (HVAC ) Equipment Market Poised to Hit $438.88 Billion by 2029 with Accelerating Growth Trends
Heating, Ventilation, And Air Conditioning (HVAC ) Equipment Market Poised to Hi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_ _x000D_ Heating, Ventilation, And Air Conditioning (HVAC ) Equipment Market Size Growth Forecast: What to Expect by 2025?_x000D_ The market size for equipment related to heating, ventilation, and air conditioning (HVAC) has seen a significant increase in recent times. The market, which was at $342.13 billion in 2024, is predicted
Future of the Supplementary Cementitious Materials Market: Strategic Analysis and Forecast to 2034
Future of the Supplementary Cementitious Materials Market: Strategic Analysis an …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_ _x000D_ Supplementary Cementitious Materials Market Size Valuation Forecast: What Will the Market Be Worth by 2025?_x000D_ The market size for supplementary cementitious materials has seen robust growth over the past few years. The value is predicted to rise from $23.55 billion in 2024 to $24.97 billion in 2025, with a
Key Trends Influencing the Growth of the Interior Design Services Market in 2025: AI-Powered Interior Design Platforms Redefine Market Dynamics
Key Trends Influencing the Growth of the Interior Design Services Market in 2025 …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_ _x000D_ What Is the Expected CAGR for the Interior Design Services Market Through 2025?_x000D_ In recent years, the market size of interior design services has seen considerable growth. It is projected to expand from $81.49 billion in 2024 to $87.09 billion in 2025, with a compound annual growth rate (CAGR)
Construction Machinery Telematics: Core Growth Enabler in the Rising Construction Activities Fuel Growth In The Construction Machinery Telematics Market Market, 2025
Construction Machinery Telematics: Core Growth Enabler in the Rising Constructio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_ _x000D_ What Will the Construction Machinery Telematics Industry Market Size Be by 2025?_x000D_ The market size of construction machinery telematics has seen a rapid growth recently. The 11.0% compound annual growth rate (CAGR) will escalate its worth from $1.16 billion in 2024 to $1.29 billion in 2025. Factors contributing to

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase